Home > News > Alltracel's Nanopeutics Subsidiary Agrees Exclusive Nanotechnology Development...
November 13th, 2006
Alltracel's Nanopeutics Subsidiary Agrees Exclusive Nanotechnology Development...
Abstract:
Alltracel Pharmaceuticals Plc., ("Alltracel", or "the Company"),(LSE: AP) the Medical Technology Company focused on the Woundcare, Oralcare and Cardiovascular Health markets today announces that
Nanopeutics(TM) s.r.o., ("Nanopeutics"), the specialist subsidiary dedicated to the commercialisation of Nanospider(TM) technology for the global woundcare market, has signed an exclusive partnership agreement with a world leader in the professional woundcare market.
Source:
PR Newswire
Related News Press |
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Military
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
New chip opens door to AI computing at light speed February 16th, 2024
NRL discovers two-dimensional waveguides February 16th, 2024
Food/Agriculture/Supplements
Silver nanoparticles: guaranteeing antimicrobial safe-tea November 17th, 2023
Night-time radiative warming using the atmosphere November 17th, 2023
DGIST and New Life Group launched a research project on "Functional beauty and health products using the latest nanotechnology" May 12th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||